Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

  1. Suvannasankha, A.
  2. Bahlis, N.
  3. Trudel, S.
  4. Weisel, K.
  5. Koenecke, C.
  6. Oriol, A.
  7. Voorhees, P.M.
  8. Alonso, A.A.
  9. Callander, N.S.
  10. Mateos, M.-V.
  11. Reddy, N.
  12. Hakim, S.
  13. LaMacchia, J.
  14. Patel, N.
  15. Williams, D.
  16. Jewell, R.C.
  17. Zhou, X.
  18. Gupta, I.
  19. Opalinska, J.
  20. Nooka, A.K.
Revista:
Cancer

ISSN: 1097-0142,  0008-543X

Any de publicació: 2024

Tipus: Article

DOI: 10.1002/CNCR.35319 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus